Trial
NCT02636283
Use of Entresto Sacubitril/Valsartan for the Treatment of Peripheral Arterial Disease
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Minnesota
Collaborators
American Heart Association
Condition
Peripheral Arterial Disease
Intervention
Entresto
Why stopped
Recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-17